Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Molecular characterization of primary lymphomas of the central nervous system towards a better prediction of evolution and personalized treatments

Published on: 07/12/2022 Reading time: 1 min
image

Researchers and clinicians from the research team co-directed by Prof. Marc SANSON and Emmanuelle HUILLARD at the Paris Brain Institute have just identified four molecular profiles of primary central nervous system lymphoma (PCNSL) that could predict the disease evolution and the risk of recurrence, allowing to orient patient care towards more effective therapies.

Primary central nervous system lymphomas

Primary central nervous system lymphomas are characterized by the proliferation of B lymphocytes, immune cells whose role is to defend the body against viruses and bacteria.

PNSCLs develop in the brain, meninges (membranes surrounding the brain), spinal cord and eyes and account for 5% of malignant brain tumors.

These tumors affect 400 new people each year and there is an increase in the number of new cases in the elderly, with those over 60 years of age accounting for over 70% of cases.

The diagnosis of these tumors is based on brain imaging and the dosage of an interleukin, an immune molecule in the cerebrospinal fluid associated with clinical symptoms such as cognitive and behavioral disorders, and signs of intracranial hypertension. Nevertheless, clinical and radiological features presented by patients are very heterogeneous leading to diagnosis difficulties.

 

A diagnosis and therapeutic orientation assistance

The work of Agusti ALENTORN, a neurologist and researcher in the "GENETICS AND DEVELOPMENT OF BRAIN TUMORS" team, aimed to define molecular profiles to help in the diagnosis and to establish an earlier adapted therapeutic management. The study involved the analysis of brain tissues from 250 patients with CNSPA associated with clinical and radiological criteria.

The joint analysis of these data lead to identify four specific patient profiles associated with a prognosis of more or less severe and rapid evolution. These results, published in the prestigious journal Annals of Oncology, will allow to better evaluate each patient with LPSNC, thus reducing the time to diagnosis and allowing for earlier and more targeted therapy.

Sources

Ann Oncol. 2022 Nov 16:S0923-7534(22)04732-9. doi: 10.1016/j.annonc.2022.11.002. Epub ahead of print. PMID: 36402300.

landscape AI
Team
NOVA: Neuro vascular interfaces in brain tumors and vascular malformations

Understanding the structure and function of neurovascular interfaces in health and disease, in the context of vascular malformations and brain tumors.

Read more

Our news on the subject

Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
See all our news